In this context, studying a Moroccan population is particularly relevant, as potential regional variations in tumor biology, genetic background, and differences in access to diagnostic and therapeutic resources may influence the prevalence, biological behavior, and prognostic impact of HER2-low breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.